171 related articles for article (PubMed ID: 27845511)
1. Pustular eruption associated with granulocyte colony-stimulating factor treatment.
Brumana MB; Russo I; Zambello R; Alaibac M
G Ital Dermatol Venereol; 2018 Apr; 153(2):276-277. PubMed ID: 27845511
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum complicating pegylated granulocyte colony-stimulating factor in Hodgkin lymphoma.
Miall FM; Harman K; Kennedy B; Dyer MJ
Br J Haematol; 2006 Jan; 132(1):115-6. PubMed ID: 16371028
[No Abstract] [Full Text] [Related]
3. Neutrophilic dermatoses in two children with idiopathic neutropenia: association with granulocyte colony-stimulating factor (G-CSF) therapy.
Prendiville J; Thiessen P; Mallory SB
Pediatr Dermatol; 2001; 18(5):417-21. PubMed ID: 11737689
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats.
Azoulay E; Attalah H; Yang K; Herigault S; Jouault H; Brun-Buisson C; Brochard L; Harf A; Schlemmer B; Delclaux C
Crit Care Med; 2003 Jan; 31(1):157-65. PubMed ID: 12545010
[TBL] [Abstract][Full Text] [Related]
5. Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer.
Cho SG; Park YM; Moon H; Kim KM; Bae SS; Kim GB; Cho HS; Kim CC; Lee KS
J Korean Med Sci; 1998 Dec; 13(6):685-8. PubMed ID: 9886182
[TBL] [Abstract][Full Text] [Related]
6. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
7. Lichenoid cutaneous drug reaction at injection sites of granulocyte colony-stimulating factor (Filgrastim).
Viallard AM; Lavenue A; Balme B; Pincemaille B; Raudrant D; Thomas L
Dermatology; 1999; 198(3):301-3. PubMed ID: 10393459
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous eruptions induced by granulocyte colony-stimulating factor in two cases of acute myelogenous leukemia.
Yamashita N; Natsuaki M; Morita H; Kitano Y; Sagami S
J Dermatol; 1993 Aug; 20(8):473-7. PubMed ID: 7504005
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous reaction to pegfilgrastim presenting as severe generalized skin eruption.
Scott WR; Silberstein L; Flatley R; Ardeshna KM; Korostoff N; Dawe S
Br J Dermatol; 2009 Sep; 161(3):717-9. PubMed ID: 19614649
[No Abstract] [Full Text] [Related]
10. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
11. [Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].
Carrato A; Guillén-Ponce C; Grande-Pulido E
Farm Hosp; 2010 Mar; 34 Suppl 1():8-11. PubMed ID: 20920851
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudomalignancy.
Fariña MC; Requena L; Dómine M; Soriano ML; Estevez L; Barat A
J Cutan Pathol; 1998 Nov; 25(10):559-62. PubMed ID: 9870676
[TBL] [Abstract][Full Text] [Related]
13. Leukocytoclastic vasculitis as a complication of granulocyte colony-stimulating factor (G-CSF) -- a case study.
Andavolu MV; Logan LJ
Ann Hematol; 1999 Feb; 78(2):79-81. PubMed ID: 10089022
[No Abstract] [Full Text] [Related]
14. Cutaneous effects of granulocyte colony-stimulating factor in healthy volunteers.
Paul C; Giachetti S; Pinquier L; Flageul B; Dubertret L; Calvo F
Arch Dermatol; 1998 Jan; 134(1):111-2. PubMed ID: 9449927
[No Abstract] [Full Text] [Related]
15. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
16. Localized cutaneous reactions to granulocyte colony-stimulating factor.
Samlaska CP; Noyes DK
Arch Dermatol; 1993 May; 129(5):645-6. PubMed ID: 7683188
[No Abstract] [Full Text] [Related]
17. Drug eruption caused by recombinant human G-CSF.
Sasaki O; Yokoyama A; Uemura S; Fujino S; Inoue Y; Kohno N; Hiwada K
Intern Med; 1994 Oct; 33(10):641-3. PubMed ID: 7530069
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
